FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306729513> ?p ?o ?g. }

• W4306729513 endingPage "1523" @default.
• W4306729513 startingPage "1523" @default.
• W4306729513 abstract "Data on the epidemiology of mild to moderately severe COVID-19 are needed to inform public health guidance.To evaluate associations between 2 or 3 doses of mRNA COVID-19 vaccine and attenuation of symptoms and viral RNA load across SARS-CoV-2 viral lineages.A prospective cohort study of essential and frontline workers in Arizona, Florida, Minnesota, Oregon, Texas, and Utah with COVID-19 infection confirmed by reverse transcriptase-polymerase chain reaction testing and lineage classified by whole genome sequencing of specimens self-collected weekly and at COVID-19 illness symptom onset. This analysis was conducted among 1199 participants with SARS-CoV-2 from December 14, 2020, to April 19, 2022, with follow-up until May 9, 2022, reported.SARS-CoV-2 lineage (origin strain, Delta variant, Omicron variant) and COVID-19 vaccination status.Clinical outcomes included presence of symptoms, specific symptoms (including fever or chills), illness duration, and medical care seeking. Virologic outcomes included viral load by quantitative reverse transcriptase-polymerase chain reaction testing along with viral viability.Among 1199 participants with COVID-19 infection (714 [59.5%] women; median age, 41 years), 14.0% were infected with the origin strain, 24.0% with the Delta variant, and 62.0% with the Omicron variant. Participants vaccinated with the second vaccine dose 14 to 149 days before Delta infection were significantly less likely to be symptomatic compared with unvaccinated participants (21/27 [77.8%] vs 74/77 [96.1%]; OR, 0.13 [95% CI, 0-0.6]) and, when symptomatic, those vaccinated with the third dose 7 to 149 days before infection were significantly less likely to report fever or chills (5/13 [38.5%] vs 62/73 [84.9%]; OR, 0.07 [95% CI, 0.0-0.3]) and reported significantly fewer days of symptoms (10.2 vs 16.4; difference, -6.1 [95% CI, -11.8 to -0.4] days). Among those with Omicron infection, the risk of symptomatic infection did not differ significantly for the 2-dose vaccination status vs unvaccinated status and was significantly higher for the 3-dose recipients vs those who were unvaccinated (327/370 [88.4%] vs 85/107 [79.4%]; OR, 2.0 [95% CI, 1.1-3.5]). Among symptomatic Omicron infections, those vaccinated with the third dose 7 to 149 days before infection compared with those who were unvaccinated were significantly less likely to report fever or chills (160/311 [51.5%] vs 64/81 [79.0%]; OR, 0.25 [95% CI, 0.1-0.5]) or seek medical care (45/308 [14.6%] vs 20/81 [24.7%]; OR, 0.45 [95% CI, 0.2-0.9]). Participants with Delta and Omicron infections who received the second dose 14 to 149 days before infection had a significantly lower mean viral load compared with unvaccinated participants (3 vs 4.1 log10 copies/μL; difference, -1.0 [95% CI, -1.7 to -0.2] for Delta and 2.8 vs 3.5 log10 copies/μL, difference, -1.0 [95% CI, -1.7 to -0.3] for Omicron).In a cohort of US essential and frontline workers with SARS-CoV-2 infections, recent vaccination with 2 or 3 mRNA vaccine doses less than 150 days before infection with Delta or Omicron variants, compared with being unvaccinated, was associated with attenuated symptoms, duration of illness, medical care seeking, or viral load for some comparisons, although the precision and statistical significance of specific estimates varied." @default.
• W4306729513 created "2022-10-19" @default.
• W4306729513 creator A5000602511 @default.
• W4306729513 creator A5000821814 @default.
• W4306729513 creator A5002555250 @default.
• W4306729513 creator A5002612986 @default.
• W4306729513 creator A5002817897 @default.
• W4306729513 creator A5002846128 @default.
• W4306729513 creator A5002854993 @default.
• W4306729513 creator A5003040413 @default.
• W4306729513 creator A5003455298 @default.
• W4306729513 creator A5003738991 @default.
• W4306729513 creator A5003883297 @default.
• W4306729513 creator A5004324032 @default.
• W4306729513 creator A5005431988 @default.
• W4306729513 creator A5005761069 @default.
• W4306729513 creator A5005786694 @default.
• W4306729513 creator A5005839226 @default.
• W4306729513 creator A5005863511 @default.
• W4306729513 creator A5005880102 @default.
• W4306729513 creator A5006443565 @default.
• W4306729513 creator A5006755486 @default.
• W4306729513 creator A5006827561 @default.
• W4306729513 creator A5006931958 @default.
• W4306729513 creator A5006995063 @default.
• W4306729513 creator A5008238190 @default.
• W4306729513 creator A5008266098 @default.
• W4306729513 creator A5008274023 @default.
• W4306729513 creator A5009556789 @default.
• W4306729513 creator A5010802478 @default.
• W4306729513 creator A5011283034 @default.
• W4306729513 creator A5011863644 @default.
• W4306729513 creator A5012122628 @default.
• W4306729513 creator A5012250229 @default.
• W4306729513 creator A5012962309 @default.
• W4306729513 creator A5013051359 @default.
• W4306729513 creator A5013350836 @default.
• W4306729513 creator A5014060810 @default.
• W4306729513 creator A5014381076 @default.
• W4306729513 creator A5014594057 @default.
• W4306729513 creator A5014719663 @default.
• W4306729513 creator A5015132268 @default.
• W4306729513 creator A5015391863 @default.
• W4306729513 creator A5015665164 @default.
• W4306729513 creator A5015948386 @default.
• W4306729513 creator A5016031031 @default.
• W4306729513 creator A5016537524 @default.
• W4306729513 creator A5017970037 @default.
• W4306729513 creator A5018000186 @default.
• W4306729513 creator A5018436398 @default.
• W4306729513 creator A5018816230 @default.
• W4306729513 creator A5019295012 @default.
• W4306729513 creator A5019419290 @default.
• W4306729513 creator A5019797613 @default.
• W4306729513 creator A5020061768 @default.
• W4306729513 creator A5020454211 @default.
• W4306729513 creator A5020456430 @default.
• W4306729513 creator A5020678290 @default.
• W4306729513 creator A5021310474 @default.
• W4306729513 creator A5021472725 @default.
• W4306729513 creator A5021621249 @default.
• W4306729513 creator A5022180714 @default.
• W4306729513 creator A5022280493 @default.
• W4306729513 creator A5022396107 @default.
• W4306729513 creator A5022632065 @default.
• W4306729513 creator A5022925806 @default.
• W4306729513 creator A5023081236 @default.
• W4306729513 creator A5023095042 @default.
• W4306729513 creator A5024929485 @default.
• W4306729513 creator A5025833954 @default.
• W4306729513 creator A5025962382 @default.
• W4306729513 creator A5026801564 @default.
• W4306729513 creator A5028599833 @default.
• W4306729513 creator A5028887909 @default.
• W4306729513 creator A5029147302 @default.
• W4306729513 creator A5029277991 @default.
• W4306729513 creator A5029555713 @default.
• W4306729513 creator A5029876857 @default.
• W4306729513 creator A5030059962 @default.
• W4306729513 creator A5030889537 @default.
• W4306729513 creator A5031816261 @default.
• W4306729513 creator A5031982491 @default.
• W4306729513 creator A5032123913 @default.
• W4306729513 creator A5032146239 @default.
• W4306729513 creator A5032547207 @default.
• W4306729513 creator A5032655677 @default.
• W4306729513 creator A5032733967 @default.
• W4306729513 creator A5032799043 @default.
• W4306729513 creator A5033198189 @default.
• W4306729513 creator A5033210115 @default.
• W4306729513 creator A5033383556 @default.
• W4306729513 creator A5033921576 @default.
• W4306729513 creator A5034070111 @default.
• W4306729513 creator A5034474234 @default.
• W4306729513 creator A5034648676 @default.
• W4306729513 creator A5034756661 @default.
• W4306729513 creator A5035078224 @default.
• W4306729513 creator A5035809732 @default.

• next